查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1478538

2033年全球基因轉殖技術市場的機會與策略

Gene Delivery Technologies Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 290 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年全球基因轉殖技術市值為21.5964億美元，到2023年複合年成長率將超過8.0%。

加大研發投入

業績期間內，基因轉殖技術市場主要由研發投入增加所驅動。技術進步、國際競爭、市場需求、監管壓力、全球挑戰、資本取得以及對研發作為長期成長和競爭的關鍵驅動力的認知推動了研發投資。這些投資透過促進新的遞送系統的開發、增強的靶向能力、改進的安全性和擴大的應用範圍而使基因轉移技術受益，最終導致遺傳基因的開發，這將為基因治療帶來更有效和個人化的治療。例如，根據美國政府機構國家科學與工程統計中心的數據，2022 年，國家機構在研究和實驗開發 (R&D) 上的支出總計為 26.44 億美元。這比上年度的25.13億美元成長了5.2%。因此，研發投資的增加促進了基因轉移技術市場的成長。

目錄

第1章執行摘要

  • 基因傳遞技術 - 市場吸引力和宏觀經濟條件

第2章 目錄

第3章 目錄

第4章表格一覽

第 5 章 報告結構

第6章市場特點

  • 一般市場定義
  • 概述
  • 基因轉移技術市場定義與細分
  • 市場區隔：按模式
    • 生物
    • 科學的
    • 身體的
  • 市場區隔：依方法
    • 體外
    • In vivo
    • In vitro
  • 市場區隔：按應用
    • 基因治療
    • 細胞療法
    • 疫苗
    • 研究

第7章 主要市場趨勢

  • 革命性的進步提高了基因編輯技術
  • 鐮狀細胞疾病突破性基因療法核准：Kasgeby 的革命性影響
  • 策略投資加速基因傳遞技術的進步
  • 增加合作夥伴關係和收購以推進基因治療

第8章基因轉移技術市場－宏觀經濟情景

  • COVID-19 基因轉殖技術市場的影響
  • 烏克蘭戰爭和基因轉移技術市場的影響
  • 高通膨對基因轉殖技術市場的影響

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 市場促進因素，2018-2023
    • 市場限制，2018-2023
  • 預測市場成長，2023-2028 年、2033 年
    • 2023-2028 年市場促進因素
    • 市場限制，2023-2028

第10章 全球基因轉殖技術市場：細分

  • 全球基因轉殖技術市場：依模式、績效與預測分類，2018-2023、2028、2033
  • 全球基因轉殖技術市場：依方法、績效與預測分類，2018-2023、2028、2033
  • 全球基因轉殖技術市場：按應用、表現與預測，2018-2023、2028、2033

第11章基因轉移技術市場：區域/國家分析

  • 全球基因轉殖技術市場：按地區、績效及預測，2018-2023、2028、2033
  • 全球基因轉殖技術市場：依國家、績效與預測，2018-2023、2028、2033

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • Horizon Discovery Group Co
  • Bio-Rad Laboratories, Inc.
  • Promega Corporation
  • OriGene Technologies Inc.
  • Takara Bio Inc.

第20章 競爭基準化分析

第 21 章競爭對手儀表板

第22章 重大併購

  • Tectonic Therapeutic Merged With AVROBIO
  • Kyowa Kirin Acquired Orchard Therapeutics
  • Syncona Acquired Applied Genetic Technologies Corp.
  • Eli Lilly Acquired Akouos
  • Eli Lilly Acquired Prevail Therapeutics

第23章機遇與策略

  • 2028年全球基因轉殖技術市場：擁有許多新業務的國家
  • 2028 年全球基因轉殖技術市場：具有許多新業務的細分市場
  • 2028 年全球基因轉移技術市場：成長策略
    • 根據市場趨勢制定策略
    • 競爭策略

第24章基因轉殖技術市場：結論與建議

  • 結論
  • 建議
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人力資源

第25章附錄

簡介目錄
Product Code: o&s1137

Gene delivery technologies encompass a diverse range of methods utilized to introduce genetic material into target cells or organisms for various applications, including gene therapy, genetic engineering and research purposes. These technologies are crucial for manipulating genetic information, enabling the delivery of therapeutic genes, gene editing tools or genetic constructs into cells to modulate gene expression or correct genetic defects.

The gene delivery technologies market consists of revenues earned by entities (organizations, sole traders or partnerships) primarily engaged in the development, production and distribution of techniques and systems for delivering genetic material. These technologies find extensive applications in biopharmaceuticals, agriculture, research and other fields.

The global gene delivery technologies market was valued at $2,159.64 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Growing Investments In Research And Development

During the historic period, the gene delivery technologies market was mainly driven by the growing investments in research and development. The investment in research and development (R&D) is growing due to technological advancements, global competition, market demand, regulatory pressures, global challenges, access to capital and the recognition of R&D as a key driver of long-term growth and competitiveness. This investment helps gene delivery technologies by enabling the development of new and improved delivery systems, enhancing targeting capabilities, improving safety profiles and expanding the range of applications, ultimately leading to more effective and personalized treatments for various diseases, including genetic disorders and cancer. For instance, according to the National Center for Science and Engineering Statistics, a US-based government agency, in 2022, state government agencies reported a total expenditure of $2.644 billion on research and experimental development (R&D). This represents a 5.2% increase from the previous year's expenditures of $2.513 billion. Therefore, growing investments in research and development contributed to the growth of the gene delivery technologies market.

Innovative Advancements To Improve Gene-Editing Technologies

Companies in the gene delivery technologies market are developing innovative products such as QIAprep& CRISPR Kit to provide rapid and sensitive characterization of clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing events in mouse or rat cells. The QIAprep& CRISPR Kit offers a streamlined workflow that includes liquid-based sample preparation, custom primer design, amplification of the region of interest and quantification of editing efficiency. For instance, in June 2021, Qiagen, a Germany-based genomics company, launched QIAprep& CRISPR Kit. This launch by QIAGEN represents a significant advancement in gene-editing technologies, providing researchers with efficient tools for analyzing and characterizing gene-editing events with high precision and sensitivity.

The global gene delivery technologies market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 67.3% of the total market in 2022.

Gene Delivery Technologies Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global gene delivery technologies market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for gene delivery technologies market? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider gene delivery technologies market; and compares it with other markets.

The report covers the following chapters

  • Introduction And Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by mode, by method and by application.
  • Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the gene delivery technologies market.
  • Global Market Size and Growth - Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.

Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by mode, by method and by application in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.

  • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for gene delivery technologies providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Mode: Biological; Chemical; Physical
  • 2) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
  • 3) By Method: Ex Vivo; In Vivo; In Vitro
  • Companies Mentioned: Horizon Discovery Group Co; Bio-Rad Laboratories Inc.; Promega Corporation; OriGene Technologies Inc.; Takara Bio Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; Canada; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; gene delivery technologies indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Gene Delivery Technologies - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Gene Delivery Technologies Market Definition And Segmentations
  • 6.4 Market Segmentation By Mode
    • 6.4.1 Biological
    • 6.4.2 Chemical
    • 6.4.3 Physical
  • 6.5 Market Segmentation By Method
    • 6.5.1 Ex Vivo
    • 6.5.2 In Vivo
    • 6.5.3 In Vitro
  • 6.6 Market Segmentation By Application
    • 6.6.1 Gene Therapy
    • 6.6.2 Cell Therapy
    • 6.6.3 Vaccines
    • 6.6.4 Research

7 Major Market Trends

  • 7.1 Innovative Advancements To Improve Gene-Editing Technologies
  • 7.2 Breakthrough Gene Therapy Approval For Sickle Cell Disease: Casgevy's Revolutionary Impact
  • 7.3 Strategic Investments Fueling Advancements In Gene Delivery Technologies
  • 7.4 Increasing Partnerships And Acquisitions For Promoting Gene Therapy

8 Gene Delivery Technologies Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Gene Delivery Technologies Market
  • 8.2 Impact Of The War In Ukraine On The Gene Delivery Technologies Market
  • 8.3 Impact Of High Inflation On The Gene Delivery Technologies Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Gene Delivery Technologies Market Segmentation

  • 10.1 Global Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Gene Delivery Technologies Market, Regional and Country Analysis

  • 11.1 Global Gene Delivery Technologies Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Gene Delivery Technologies Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Gene Delivery Technologies Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate tax structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Gene Delivery Technologies Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major Companies
  • 14.2 Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Gene Delivery Technologies Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Gene Delivery Technologies Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Gene Delivery Technologies Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Major Companies
  • 17.2 Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Major Companies
  • 18.2 Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Gene Delivery Technologies Market, Segmentation By Method, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Gene Delivery Technologies Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Horizon Discovery Group Co
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Bio-Rad Laboratories, Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Promega Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 OriGene Technologies Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Takara Bio Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Tectonic Therapeutic Merged With AVROBIO
  • 22.2 Kyowa Kirin Acquired Orchard Therapeutics
  • 22.3 Syncona Acquired Applied Genetic Technologies Corp.
  • 22.4 Eli Lilly Acquired Akouos
  • 22.5 Eli Lilly Acquired Prevail Therapeutics

23 Opportunities And Strategies

  • 23.1 Global Gene Delivery Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Gene Delivery Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Gene Delivery Technologies Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Gene Delivery Technologies Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer